Despite many potential benefits of metformin to target aging-related ailments— and despite a recommendation from the American Diabetes Association that it be tried before any other drug for newly diagnosed Type 2 diabetics — a recent study found that only about half of all such people get metformin as their first prescribed medication. Niteesh Choudhry, associate professor of medicine at Brigham and Women’s Hospital, led the study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?